Clinical Trial Update: First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of AMG 579 in healthy subjects and individuals with stable schizophrenia; the trial status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• AMG 579

Snippet

Sponsor: Amgen | Conditions: Schizophrenia | Phase 1 | Status: TERMINATED